Immunoprevention of basal cell carcinomas with recombinant hedgehog-interacting protein.

J Exp Med · 2004 · PMC2212732 · PMID 15024045

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

marginally significantP = 0.07so close (0.05 < p ≤ 0.1)

There were significant differences between the four treatment groups in lesion numbers (P < 0.001), marginally significant reductions in tumor burden (P = 0.07), and no statistically significant differences in BCC area (P = 0.37).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.